Startups
GobiX GmbH is a Swiss MedTech start-up founded in April 2020 to address the COVID-19 test kit shortage using 3D printing technology. GobiX currently focuses on innovations using 3D printing technologies in the field of diagnostics and coronavirus consulting services.
Overview
Location
Switzerland, Zug, Inwil
Employees
1-10
Founded date
2020
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 14, 2021 | Mit TestifiX schneller zum passenden Covid-Reisezertifikat | |
| Aug 17, 2020 | From the shortage of COVID-19 test kits to a medtech start-up | |
| Aug 17, 2020 | From the shortage of COVID-19 test kits to a medtech start-up | The swabs and viral-collection fluid normally used in Switzerland prior to the COVID-19 crisis were produced in other countries, leaving Switzerland vulnerable to supply chain disruption. Because of global shortage, and in order to be indep... |
Reviews 0
FAQ about GobiX
When was GobiX founded?
GobiX was founded in 2020.
What has the press written about GobiX?
Parsers VC has collected 4 articles mentioning GobiX, among them “Mit TestifiX schneller zum passenden Covid-Reisezertifikat” (Apr 14, 2021) and “From the shortage of COVID-19 test kits to a medtech start-up” (Aug 17, 2020).
Is GobiX still active?
Yes, GobiX is active; its latest activity on Parsers VC dates from Apr 14, 2021.